`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`TEVA PHARMACEUTICALS USA INC.
`Petitioner
`v.
`MONOSOL RX, LLC,
`Patent Owner
`
`
`
`
`
`IPR2016-00281
`Patent 8,603,514 B2
`
`IPR2016-00282
`Patent 8,017,150 B21
`
`
`
`
`DECLARATION OF LINDA ROGERS IN SUPPORT OF
`PETITIONER’S MOTION TO CORRECT FILING DATE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1 Petitioner attests that the word-for-word identical paper is filed in each proceeding
`
`
`
`Page | 1
`
`identified in the heading.
`
`
`
`TEVA EXHIBIT 1029
`TEVA PHARMACEUTICALS USA, INC. V. INDIVIOR UK LIMITED
`IPR2016-00280
`
`
`
`
`
`
`
`I, Linda Rogers, hereby declare:
`
`1.
`
`I am legal assistant at the law firm of Goodwin Procter LLP, counsel
`
`of record for Petitioner Teva Pharmaceuticals USA Inc. I make this Declaration in
`
`support of Petitioner’s Motion to Correct the Filing Date of IPR2016-00281 and
`
`IPR2016-00282 from December 4, 2015 to December 3, 2015. This Declaration is
`
`based on my own personal knowledge and, if called as a witness, I could and
`
`would testify competently to the facts in this Declaration.
`
`2.
`
`As laid out below, on the evening of December 3, 2015, Petitioner’s
`
`counsel filed three IPR petitions concerning U.S. Patent Nos. 8,475,832,
`
`8,603,514, and 8,017,150, which will be referred to herein as the “’280 petition,”
`
`“’281 petition,” and “’282 petition.”
`
`3.
`
`During the course of the evening, we experienced technical
`
`difficulties using the USPTO’s Patent Trial and Appeal Board Patent Review
`
`Processing System (“PRPS”) that prevented us from submitting the petitions in
`
`these proceedings by midnight EST.
`
`4.
`
`I began filing the ’280 petition and related documents at
`
`approximately 9:45pm EST on December 3rd. The process involves: (1) logging
`
`into PRPS under an authorized account (in this case, the account of Elizabeth
`
`Holland, who is lead counsel in these proceedings); (2) filling out forms
`
`requesting bibliographic information about the case, the patent at issue, and the
`
`
`
`
`
`Page | 2
`
`TEVA EXHIBIT 1029
`TEVA PHARMACEUTICALS USA, INC. V. INDIVIOR UK LIMITED
`IPR2016-00280
`
`
`
`attorneys of record; (3) providing payment information (e.g., credit card and/or
`
`deposit account information); and (4) uploading the petition and related
`
`documents to the PRPS server.
`
`5.
`
`During the process of uploading documents filed in connection with
`
`the ’280 petition to the PRPS server, I observed that PRPS was functioning highly
`
`unusually. In particular, PRPS repeatedly froze during the ’280 petition upload
`
`process.
`
`6.
`
`For example, when I selected certain exhibits for upload, the browser
`
`would show a spinning circle. This circle usually appears only for a few seconds
`
`while the selected document is uploading. On December 3rd, however, the circle
`
`appeared for much longer than usual in connection with several exhibits. When
`
`this happened, the circle would stop spinning after several seconds to several
`
`minutes, and the PRPS system stopped functioning altogether.
`
`7. When this occurred, I was unable to take any action whatsoever
`
`(including actions such as selecting another option on PRPS, closing the browser
`
`window or opening new windows). The computer itself and other programs,
`
`however, remained functional. (That evening, I was using a reliable computer
`
`that was connected to the Internet via high-speed connections. I accessed the
`
`PRPS system via Internet Explorer.)
`
`8.
`
` When PRPS malfunctions in this way, the only way to re-start the
`
`
`
`Page | 3
`
`
`
`
`
`TEVA EXHIBIT 1029
`TEVA PHARMACEUTICALS USA, INC. V. INDIVIOR UK LIMITED
`IPR2016-00280
`
`
`
`PRPS session that I am aware of is to force-close the Internet Explorer browser
`
`(i.e., selecting CTRL-ALT-DEL and shutting down the browser through the task
`
`menu), re-open the browser, re-login to PRPS, and attempt to resume the filing.
`
`This PRPS “rebooting” process took several minutes each time.
`
`9. When this happened on the night of December 3rd, I repeatedly
`
`engaged in the force-close process. Once logged back into the PRPS system,
`
`though, the session was administratively “locked” from access. In other words,
`
`when the PRPS session was re-started, the screen displayed a large graphic of a
`
`“padlock” and an error message that prevented any further work on the filing.
`
`Ultimately, a menu option to “unlock” the session was located to resume filing,
`
`but this additional step of “unlocking” the locked filing session further added
`
`additional time to the overall filing.
`
`10. Once unlocked, the filing was able to be resumed, but the document
`
`associated with the attempted upload was gone. I was required to re-trace all of
`
`the uploading steps for each document for which the error occurred.
`
`11. This “freezing”, re-starting, locking, and unlocking of PRPS on
`
`several occasions added a significant amount of time to each filing. The total
`
`time to complete the ’280 petition filing took nearly an hour and a half, almost an
`
`hour and ten minutes longer than usual.
`
`12.
`
`I have previously completed PRPS filings using the same computer
`
`
`
`Page | 4
`
`
`
`
`
`TEVA EXHIBIT 1029
`TEVA PHARMACEUTICALS USA, INC. V. INDIVIOR UK LIMITED
`IPR2016-00280
`
`
`
`running the same Internet Explorer browser without these difficulties. In fact, in
`
`the past, similar documents were uploaded from my computer using the same
`
`Internet browser and connected through the same system to PRPS in a matter of
`
`seconds.
`
`13.
`
`In my experience, a complete filing with a similar number of exhibits
`
`to that of the ’280 and ’282 petitions typically takes 20 minutes or less each. In
`
`all, the total time to upload the complete set of documents in the proceedings took
`
`hours—significantly longer than expected and experienced in other, similar PRPS
`
`filings.
`
`14.
`
`I believe that the repeated crashes and restarts were caused by the
`
`PRPS system.
`
`15.
`
`I ultimately uploaded the complete set of ’280 petition-related
`
`documents and paid the required fee before midnight on December 3rd using a
`
`firm American Express card. PRPS generated a notice of the successful filing at
`
`approximately 11:11PM, and I was instructed by Ms. Yost to immediately begin
`
`the filing what would become the ’282 petition.
`
`16.
`
`I experienced the same problems with the PRPS system when
`
`attempting to file the documents associated with the ’282 petition. The system
`
`crashed on several occasions.
`
`17. Ultimately, I believe the petition and exhibits associated with the
`
`
`
`Page | 5
`
`
`
`
`
`TEVA EXHIBIT 1029
`TEVA PHARMACEUTICALS USA, INC. V. INDIVIOR UK LIMITED
`IPR2016-00280
`
`
`
`’282 proceeding were uploaded to the PRPS server prior to midnight EST.
`
`18.
`
`I also attempted to submit payment for the ’282 proceeding prior to
`
`midnight, which, in the PRPS system, must be entered, submitted and actually
`
`“clear” before users are provided the opportunity to click “submit” and complete
`
`the overall filing. Prior to midnight, I submitted payment for the ’282 petition via
`
`a deposit account, which was declined. I thereafter attempted to use several
`
`different firm American Express credit cards and deposit accounts to submit
`
`payment. At the time I was inputting these different payment methods, I did not
`
`know the reasons why the payments were declined. Eventually, payment was
`
`successful using a different deposit account, and a payment acknowledgment was
`
`received at 12:04 AM EST. I then completed the forms regarding counsel and
`
`power of attorney information and clicked “submit.” The entire filing was
`
`confirmed at 12:09 AM EST.
`
`19.
`
`I hereby declare that all statements made herein of my own knowledge
`
`are true and that all statements made on information and belief are believed to be
`
`true, and further that these statements were made with the knowledge that willful
`
`false statements and the like so made are punishable by fine or imprisonment, or
`
`both, under Section 1001 of Title 18 of the United States Code.
`
`Dated: February 29, 2016
`
`Linda Rogers
`
`T‘
`
`TEVA EXHIBIT 1029
`TEVA PHARMACEUTICALS USA, INC. V. INDIVIOR UK LIMITED
`IPR2016-00280